Work

Robot-assisted laparoscopic augmentation ileocystoplasty for neurogenic bladder: case report and structured literature review

Year: 2026

Type: article

Abstract: Background: Bladder augmentation is generally reserved for selected patients failing conservative management or with unsafe storage pressures/compliance for neurogenic bladder (NGB) patients. The robotic-assisted laparoscopic approach for urinary issues has gained attention. This study evaluates the feasibility and safety of robot-assisted laparoscopic augmentation ileocystoplasty (RALAI) in treating NGB. Methods: O, and a post-void residual volume of 250 ml. The patient underwent RALAI with the creation of a Mitrofanoff conduit. Subsequently, we conducted a comprehensive literature review on RALAI for NGB patients, covering the period from January 1, 2004, to December 31, 2024, utilizing databases such as PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang. The search employed keywords including "neurogenic bladder," "ileocystoplasty," and "robot." Measurements: The primary objective was to ascertain the surgical success rate of RALAI without conversion to open surgery. Secondary objectives included assessing complications within 90 days postoperatively, such as stomal complications, intestinal issues, and infections. Results: The RALAI procedure was completed without conversion to open surgery in 86/92 patients (93.5%, 95% CI 88.4-98.5%), with a conversion rate of 6.5% (95% CI 1.6-11.4%). No intraoperative complications (e.g., visceral injury, hemorrhage or anesthetic events) directly attributable to the surgical technique were recorded). In the pooled cohort of 92 patients, the RALAI procedure demonstrated favorable patient-centred outcomes: postoperative bladder capacity increased substantially in the majority of reported cases; the rate of early postoperative complications was 38.0% (95% CI 28.1-48.0%), with 13.0% (95% CI 6.2-19.9%) requiring secondary surgical revision. Urinary tract infections occurred in 14.1% of patients. In our own index case, the patient achieved bladder capacity of 380 ml and social continence, resumed intermittent catheterization and spontaneous voiding, and remained free of urinary tract infections (UTIs) and bladder stones at 3 years. Conclusions: Our findings indicate that RALAI is a feasible minimally invasive option for selected NGB patients, with a conversion rate of approximately 6.5%. However, the true value of the procedure should be assessed by patient-centred outcomes, which our pooled data suggest are promising.

Source: Frontiers in Surgery

DOI: 10.3389/fsurg.2026.1767111

Authors: Jia You, Cheng Lan, Xu-fei Duan, Hai-tao Chen

Institutions: Wuhan Children's Hospital, Huazhong University of Science and Technology, Central Hospital of Wuhan

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801